Catalyst Pharma sues FDA over approval of cheaper rival drug
Catalyst Pharmaceuticals Inc, which has come under fire for the high price tag on its rare disease drug, on Wednesday sued the U.S. Food and Drug Administration to challenge the recent approval of a lower-cost rival drug.
from Reuters: Health News https://reut.rs/31pEFVC
http://bit.ly/2zwRqiM